CYTK

CYTK R&D Expense Growth

19.59%Fiscal year

Period ending:

CYTK FY R&D Growth (YoY)%
CYTK FY R&D Growth (YoY)116.81%-41.47%
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

CYTK r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Cytokinetics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
19.5909%
2.8126%
37.0869%
50.5665%
64.9679%
12.5701%
-3.3769%
-1.2858%
50.7521%
29.0939%
4.4388%
-10.1598%
38.7369%
-4.1391%
-2.1861%
-4.5858%
-26.1538%
1.0527%
8.4571%
21.3335%
1.7174%
17.295%
19.6313%
35.6042%
101.49%
0%

Compare r&d expense growth

All CYTK financial metrics · CYTK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.